Annual Drug Patent Expirations for NARCAN
Narcan is a drug marketed by Adapt, Bristol Myers Squibb, and Emergent and, and is included in five NDAs. It is available from seven suppliers. There are eight patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for NARCAN.
This drug has twenty-eight patent family members in fourteen countries.
The generic ingredient in NARCAN is naloxone hydrochloride. Seven suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
